Metabolomic profiling of mouse mammary tumor-derived cell lines reveals targeted therapy options for cancer subtypes

被引：0
|
作者：
Martin P. Ogrodzinski
Shao Thing Teoh
Sophia Y. Lunt
机构：
[1] Michigan State University,Department of Biochemistry and Molecular Biology
[2] Michigan State University,Department of Physiology
[3] Michigan State University,Department of Chemical Engineering and Materials Science
来源：
Cellular Oncology | 2020年 / 43卷
关键词：
Breast cancer; Cancer subtypes; Targeted therapy; Metabolic profile; Metabolomics; Mass spectrometry;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1117 / 1127
页数：10
相关论文
共 50 条
  • [31] Tumor-derived mesenchymal stem cells and orthotopic site increase the tumor initiation potential of putative mouse mammary cancer stem cells derived from MMTV-PyMT mice
    Lanza, Denise Grant
    Ma, Jun
    Guest, Ian
    Uk-Lim, Chang
    Glinskii, Anna
    Glinsky, Gennadi
    Sell, Stewart
    TUMOR BIOLOGY, 2012, 33 (06) : 1997 - 2005
  • [32] Global expression profiling and pathway analysis of mouse mammary tumor reveals strain and stage specific dysregulated pathways in breast cancer progression
    Mei, Yan
    Yang, Jun-Ping
    Lang, Yan-Hong
    Peng, Li-Xia
    Yang, Ming-Ming
    Liu, Qing
    Meng, Dong-Fang
    Zheng, Li-Sheng
    Qiang, Yuan-Yuan
    Xu, Liang
    Li, Chang-Zhi
    Wei, Wen-Wen
    Niu, Ting
    Peng, Xing-Si
    Yang, Qin
    Lin, Fen
    Hu, Hao
    Xu, Hong-Fa
    Huang, Bi-Jun
    Wang, Li-Jing
    Qian, Chao-Nan
    CELL CYCLE, 2018, 17 (08) : 963 - 973
  • [33] Targeted disruption of β1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction
    White, DE
    Kurpios, NA
    Zuo, DM
    Hassell, JA
    Blaess, S
    Mueller, U
    Muller, WJ
    CANCER CELL, 2004, 6 (02) : 159 - 170
  • [34] Targeted Proteomics-Based Quantitative Protein Atlas of Pannexin and Connexin Subtypes in Mouse and Human Tissues and Cancer Cell Lines
    Tachikawa, Masanori
    Kaneko, Yosuke
    Ohtsuki, Sumio
    Uchida, Yasuo
    Watanabe, Michitoshi
    Ohtsuka, Hideo
    Terasaki, Tetsuya
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 109 (02) : 1161 - 1168
  • [35] Genetic mutation profiling reveals biomarkers for targeted therapy efficacy and prognosis in non-small cell lung cancer
    Bai, Hao
    Zhou, Yan
    Liu, Wanting
    Xu, Wang-yang
    Cheng, Lei
    Huo, Yingying
    Ji, Hao
    Xiong, Liwen
    HELIYON, 2024, 10 (06)
  • [36] Tumor-derived Vimentin as a novel biomarker for distinct subtypes predicting adjuvant chemotherapy resistance and T-cell-inflamed phenotype in small cell lung cancer
    Deng, Chaoqiang
    Wang, Yue
    Fu, Fangqiu
    Li, Di
    Zheng, Qiang
    Jin, Yan
    Li, Yuan
    Chen, Haiquan
    Zhang, Yang
    MEDCOMM, 2023, 4 (05):
  • [37] Enhanced anticancer activity of 5-FU in combination with Bestatin: Evidence in human tumor-derived cell lines and an H22 tumor-bearing mouse
    Li, Jin
    Wang, Xuejian
    Hou, Jinning
    Huang, Yongxue
    Zhang, Yingjie
    Xu, Wenfang
    DRUG DISCOVERIES AND THERAPEUTICS, 2015, 9 (01): : 45 - 52
  • [38] Characterization and targeted therapy using patient tumor-derived 3-D spheroids in a metastatic castrate resistant prostate cancer model.
    Kase, Adam M.
    Tan, Winston
    Copland, John A.
    CANCER RESEARCH, 2021, 81 (13)
  • [39] Single-Cell Transcriptomic Analysis of Tumor-Derived Fibroblasts and Normal Tissue-Resident Fibroblasts Reveals Fibroblast Heterogeneity in Breast Cancer
    Sebastian, Aimy
    Hum, Nicholas R.
    Martin, Kelly A.
    Gilmore, Sean F.
    Peran, Ivana
    Byers, Stephen W.
    Wheeler, Elizabeth K.
    Coleman, Matthew A.
    Loots, Gabriela G.
    CANCERS, 2020, 12 (05)
  • [40] INFLUENCE OF TUMOR-DERIVED FIBROBLASTS AND 1,25-DIHYDROXYVITAMIN D-3 ON GROWTH OF BREAST-CANCER CELL-LINES
    LEFEBVRE, MF
    GUILLOT, C
    CREPIN, M
    SAEZ, S
    BREAST CANCER RESEARCH AND TREATMENT, 1995, 33 (03) : 189 - 197
12345